aid: amber
name: Amber Bio
description: 'Amber Bio is a San Francisco-based biotechnology company founded in 2021
  that is pioneering RNA-based gene editing. Its multi-kilobase RNA writing platform
  is designed to correct thousands of diverse mutations across a patient population
  with a single product, rather than requiring an independent therapy for each separate
  mutation. The company positions the approach as safe (minimal off-target effects),
  reversible, and capable of edits far larger than conventional base or prime editing,
  targeting previously undruggable genetic disease populations. Amber Bio launched
  publicly in August 2023 with an oversubscribed $26M seed round co-led by Playground
  Global and Andreessen Horowitz Bio + Health. It is a pre-clinical therapeutics company
  and publishes no public API, developer portal, or SDK surface.'
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/6245f65e49aca16254e8bad8/62472aefc8c77a733e1635a4_Webclip.png
url: https://raw.githubusercontent.com/api-evangelist/amber/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- Playground Global
- Eli Lilly
- Pillar VC
- Hummingbird
- Retinal Degeneration Fund
- SV Angel
x-tier: stub
x-tier-reason: no-public-api-surface
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Gene Editing
- RNA
- Therapeutics
- Life Sciences
- Precision Medicine
- Pre-Clinical
apis: []
common:
- type: DomainSecurity
  url: security/amber-domain-security.yml
- type: Website
  url: https://www.amber.bio/
- type: About
  url: https://www.amber.bio/#about-us
- type: Team
  url: https://www.amber.bio/#team
- type: News
  url: https://www.amber.bio/#news
- type: Careers
  url: https://www.amber.bio/careers
- type: LinkedIn
  url: https://www.linkedin.com/company/amber-bio
- type: WellKnown
  url: well-known/amber-well-known.yml
- type: LLMsTxt
  url: llms/amber-llms.txt
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: minimal
  artifacts_added: 3
  pass: local-v1
  note: >-
    Stub resolved to Amber Bio (amber.bio) — the a16z Bio + Health seed co-lead.
    Pre-clinical RNA gene-editing therapeutics company with a single-page Webflow
    marketing site and a /careers page. No API, developer portal, docs, SDK,
    package, event, GitHub organization, or .well-known surface exists; the
    DX/runtime-semantics tier is genuinely N/A rather than missing. Probes:
    all /.well-known/* and /llms.txt 404; no vulnerability-disclosure program and
    no trust center; TLS 1.3 + HSTS present, DNSSEC and CAA absent, SPF and DMARC
    present (dmarc policy none). Site-footer Privacy Policy and Terms of Service
    are dead "#" anchors, so no pointers were emitted for them. Do not re-queue
    for API artifact enrichment unless the company ships a developer surface.